This Biotech Stock 135% Jump Trims $44M: What Now Today
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
This guide compares risk levels between bonds and stocks in retirement, outlining factors like market cycles, duration, and income needs.
28,627 articlesA biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
When a familiar tech name moves lower mid-session, investors want answers. This guide breaks down why intel stock dro...
A major box-office milestone puts spotlight on how music biopics monetize beyond ticket sales. Learn practical, money...
When a member of a royal family steps into the public eye after a major news cycle, personal finances can feel the pr...
Kinsale Capital is carving a niche in the specialty insurance market. This article breaks down why it might be a stro...
Oil prices march upward again as tensions between the U.S. and Iran flare, pushing Brent above $80 and complicating i...
As AI reshapes industries, one top AI stock has fallen into a buy zone. This guide breaks down why the stock looks ch...
Two NASA contract wins have put Intuitive Machines on investors’ radar, but do they move the needle for long-term ret...
Despite fintech rivals, Western Union remains a durable money-movement platform with a vast network and steady cash f...
As seniors increasingly seek to live at home, lenders, insurers, and contractors are rallying around funding for safe...
As SpaceX moves deeper into the public market, investors face a volatile ride. This article lays out credible scenari...
A veteran tech analyst challenges the AI-rotation selloff, arguing software names are undervalued as rate fears ease ...